FIELD: medicine; ophthalmology.
SUBSTANCE: invention relates to medicine, specifically to ophthalmology, and can be used to prevent or ameliorate macular degeneration. Method comprises administering an effective amount of a complement pathway inhibitor to a subject in need thereof, wherein complement pathway inhibitor is an antibody or antigen-binding fragment thereof, wherein antibody or antigen-binding fragment specifically binds to factor D.
EFFECT: invention provides effective treatment for age-related macular degeneration, diabetic retinopathy in a patient in need thereof.
19 cl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| APPLICATION OF COMPLEMENT PATHWAY INHIBITORS FOR TREATMENT OF EYE DISEASES | 2006 |
|
RU2417099C2 |
| PREVENTING AND TREATING COMPLEMENT-CAUSED OCULAR PATHOLOGIES | 2008 |
|
RU2522976C2 |
| C3b ANTIBODIES AND METHODS FOR PREVENTION AND TREATMENT OF COMPLEMENT-RELATED DISORDERS | 2008 |
|
RU2473563C2 |
| COMPOSITIONS AND METHODS OF SPHINGOSINE-1-PHOSPHATE BINDING | 2007 |
|
RU2460541C2 |
| NOVEL ANTIBODIES | 2008 |
|
RU2490277C2 |
| METHOD FOR DETERMINING ANTIBODIES THAT INDUCE COMPLEMENT-DEPENDENT CYTOTOXICITY | 2015 |
|
RU2698205C2 |
| METHODS OF INHIBITING OCULAR ANGIOGENESIS | 2009 |
|
RU2530583C2 |
| COMBINED THERAPY WITH USING ALPHA5BETA1 ANTAGONISTS | 2007 |
|
RU2465282C2 |
| ANTIBODIES RECOGNISING CARBOHYDRATE CONTAINING EPITOPE ON CD-43 AND CEA EXPRESSED ON CANCER CELLS, AND METHODS OF USING SUCH | 2007 |
|
RU2461572C2 |
| METHOD OF DESTROYING CELLS USING EFFECTOR FUNCTIONS OF ANTI-EphA4 ANTIBODIES | 2007 |
|
RU2429246C2 |
